Protocol tips
Upstream tips |
Protocol tips |
Downstream tips |
- XL10-Gold cells are resistant to tetracycline and chloramphenicol. If the mutagenized plasmid contains only the tetR or camR resistance marker, an alternative strain of competent cells must be used |
- Use only the Dpn I enzyme provided; do not substitute with an enzyme from another source. |
|
Upstream tips |
- XL10-Gold cells are resistant to tetracycline and chloramphenicol. If the mutagenized plasmid contains only the tetR or camR resistance marker, an alternative strain of competent cells must be used |
Protocol tips |
- Use only the Dpn I enzyme provided; do not substitute with an enzyme from another source. |
Publication protocol
Reporter gene assays
LNCaP cells were seeded in 24-well plates at a density of 70 000 cells/well phenol red-free RPMI medium supplemented with 10% DSS. Forty-eight hours later, the cell medium was replaced with fresh RPMI phenol red-free medium supplemented with 10% DSS with or without 1 nM R1881. Each well was transfected with 500 ng DNA, consisting of: 100 ng of firefly luciferase pGL3 vectors, 100 ng luciferase vector (pRL-TK) and 300 ng Bluescribe plasmid DNA as carrier DNA. Cells were transfected using Lipofectamine LTX and PLUS Reagent (Invitrogen) according to the manufacturer's instructions. Twenty-four hours following transfection, firefly and luciferase activities were determined using the Dual-Glo Luciferase Assay System (Promega). Firefly luciferase readings were subsequently normalized against the control luciferase such that the luciferase activity served to control for transfection efficiency.
Full paper
Login or
join for free to view the full paper.
Reviews
QuikChange Multi Site-Directed Mutagenesis Kit from Agilent Technologies has not yet been reviewed for this experiment
We'd love it if you would be the first to write a review!
Discussion
Start your discussion
Share your thoughts or question with experts in your field
Start a discussion
Papers
Check out relevant papers found by Labettor's AI that are relevant for performing Site Directed Mutagenesis (SDM) Human - Point mutation LNCaP GNMT using QuikChange Multi Site-Directed Mutagenesis Kit from Agilent Technologies.
Paper title
Characterisation of the androgen regulation of glycine -methyltransferase in prostate cancer cells
Manufacturer protocol
Download the product protocol from Agilent Technologies for QuikChange Multi Site-Directed Mutagenesis Kit below.
Download manufacturer protocol
Videos
Check out videos that might be relevant for performing Site Directed Mutagenesis (SDM) Human - Point mutation LNCaP GNMT using QuikChange Multi Site-Directed Mutagenesis Kit from Agilent Technologies. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.
We haven't found any additional videos for this experiment / product combination yet.